News
Dow Jones Top Company Headlines at 9 PM ET: UnitedHealth Group Is Under Criminal Investigation for Medicare Fraud | Dickâs ... UnitedHealth Group Is Under Criminal Investigation for Medicare Fraud ...
Dow Jones Top Company Headlines at 7 PM ET: Cisco Systems Boosts Outlook After Posting Higher Profit, Sales | Dickâs ... Cisco Systems Boosts Outlook After Posting Higher Profit, Sales The ...
Investor's Business Daily on MSN8h
Novo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna SkyrocketingNovo Nordisk inked an obesity deal worth up to $2.2 billion on Wednesday, and sent shares of Septerna into the stratosphere.
Zacks Investment Research on MSN9h
CVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...
Novo Nordisk is doubling down on its oral drug strategy for obesity with a new partnership worth up to $2.2bn with Septerna.
Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills.
Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback